Location

Embassy Suites Hotel
Chesterbrook, PA
Presented by: The Pharmaceutical Consulting Consortium International Inc.

Directions:Take Rt 202 to the Chesterbrook exit (that’s two exits South of the Devon exit), turn right at the end of the exit ramp and you’ll see the hotel on your right. If you are going North on 202, get off at the Chesterbrook exit and turn left at the traffic light and drive back over Rt 202. You’ll see the hotel on your right. Proceed to the traffic light and turn right into the parking lot of the hotel. Their phone is: 610 647 6700

Co-Hosted by:
Enterprise Forum Philadelphia
Life Sciences Collaborative
Pharmaceutical Consulting Consortium International, Inc.

Sponsored by:
Duane Morris
Eisner Amper
i2n
NJIT
Science Center

Description

PCCI’s 9th Annual Roundtable
‘Precision Medicine: From Patient to Payor’
Monday, May 11, 2015
6:00 PM: Networking
7:00 PM: Dinner
8:00 PM: Roundtable & Discussion


Members: $65
Non-Members: $75
Parking is Free

Moderator

Michael Liebman, PhD; Managing Director of IPQ Analytics and Strategic Medicine Inc.;
Adjunct Professor of Pharmacy and Physiology at Drexel College of Medicine;
Adjunct Professor of Medicine, First University Hospital of Wenzhou, China
 

Panelists

Bruce Bowman, MD, PhD, MSPH; Medical Director, Cancer Genetics and Stem Cell Biology Helen F. Graham Cancer Center, Christiana Care Health System
Karen Gripp, MD; Division Chief, Division of Genetics, Department of Pedriatrics, Nemours Children’s Health Hospital
Paul Mc Gonigle, PhD; Professor, Department of Pharmacology and Physiology; Director Drug Discovery and Development Program, Drexel College of Medicine
Iris Melendez; Patient Advocate; President, Nathaniel Adamczyk Foundation
Nick Sarlis, MD, PhD; Vice-President Head Medical Affairs for Incyte Corporation

 

PRECISION MEDICINE: GAME CHANGER? OR SOMETHING LESS?

What will be the primary drivers: Genomic Technologies or personalized patient-centric healthcare delivery? How will it be regulated? Who will pay for it? What impact will it have on the development of new drugs and devices? Where do physicians and hospitals fit in? How can Big Pharma survive such a proposed sweeping change? Will the US economy support it? Will patients finally have a say in the healthcare equation?

On May 11th we will tackle these questions and more when Michael Liebman moderates a distinguished panel of experts to discuss what promises to be an historic paradigm shift in the delivery of health care as we know it.

Excerpt from the NIH Website for Precision Medicine:

“Precision medicine is an emerging approach for disease treatment and prevention that takes into account individual variability in genes, environment, and lifestyle for each person. While significant advances in precision medicine have been made for select cancers, the practice is not currently in use for most diseases. Many efforts are underway to help make precision medicine the norm rather than the exception. To accelerate the pace, President Obama has now unveiled the Precision Medicine Initiative — a bold new enterprise to revolutionize medicine and generate the scientific evidence needed to move the concept of precision medicine into every day clinical practice.”

The program will begin with introductory remarks followed by a lively panel discussion for the first hour. For the last 30 minutes we will take questions from the audience.

The event will be webcast. Those who cannot join the meeting can still participate. Webcast registration will be $35. A password will be given.

Become a member of PCCI: Lifelong membership is still $100, just click on rxpcci.com and follow directions.
Every PCCI meeting is webcast. The webcast recording of the PCCI meetings will be posted on the PCCI website rxpcci.com and webcast live via the internet during the event.